Current role
Yen-Ching Chua
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yen-Ching Chua
Tango Therapeutics, Inc. reported in an 8-K filed April 15, 2026 that Yen-Ching Chua was appointed Chief Development Operations Officer, effective June 1, 2026.
“Yen-Ching Chua has been appointed Chief Development Operations Officer effective June 1, overseeing clinical operations including data management, as well as quality, clinical compliance and clinical sourcing.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tango Therapeutics, Inc. (TNGX)
SEC 8-K
Current2026-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO, Board Member
- Jessica Newcomb Chief Accounting Officer
- Adam Crystal Board Member
- Daniella Beckman Board Member
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.